ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633273 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633273; 2) Community: the network communities that were significantly associated with the response to NSC 633273; 3) Molecule: the relationships between components within communities and NSC 633273; 4) MDR: the compounds that were significantly associated with the NSC 633273.

NSC Compound Enrichment Correlation
NSC 752503 2,7-Bis-[2-(3,4,5-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone dipara-toluensulfonate dihydrate salt 0.0385613993886001 0.3651681
NSC 756406 GW852849X 0.0385613993886001 0.31696548
NSC 756413 GW876790X 0.0385613993886001 -0.31606887
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 0.0385613993886001 0.21523062
NSC 762611 Null 0.0385613993886001 0.18685781
NSC 7821 [6-(Dimethylamino)-3H-phenoxazin-3-ylidene]dimethylammonium chloride 0.0385613993886001 0.45486587
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0385613993886001 0.41973268
NSC 8985 WLN: 1R D-I-R D1 &E &6/14 0.0385613993886001 0.25477511
NSC 100290 Doxypyrromycin hydrochloride 0.0414190425892865 0.32285158
NSC 10466 Aizen Magenta 0.0414190425892865 0.25189622
Total:114  Current:86    [First] [Prev] [Next] [Last]